Ocera Therapeutics – CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. Confidential (September 27th, 2013)
UCL Business PLC, a public limited company incorporated under the laws of England and Wales with company registration number 02776963 and with its registered office at The Network Building, 97 Tottenham Court Road, London W1T 4TP ("UCL"); and
Ocera Therapeutics – Ocera Therapeutics, Inc. 2005 Stock Plan Notice of Stock Option Grant (August 14th, 2013)
This Option may be exercised, in whole or in part, at any time after the Date of Grant. So long as your Continuous Service Status with the Company continues, the Shares underlying this Option shall vest in accordance with the following schedule: twenty-five percent (25%) of the total number of Shares subject to the Option shall vest on the 1st anniversary of the Vesting Commencement Date and 1/36th of the total remaining number of Shares subject to the Option shall vest on the same day of each month thereafter.
Ocera Therapeutics – Th Erap Eutics (August 14th, 2013)
The purpose of this letter is to set forth the understanding we have reached with respect to the amendment of that certain letter agreement dated as of September 12, 2005 by and between you and Ocera Therapeutics, Inc. (formerly known as "Renovia, Inc.") (the "Company"), which sets forth the terms of your employment with the Company. That agreement is as follows: